Skip to content

Multi-Center Clinical Study on the Treatment of Female Stress Urinary Incontinence with AI Temperature Controlled Radiofrequency Technology

Multi-Center Clinical Study on the Treatment of Female Stress Urinary Incontinence with AI Temperature Controlled Radiofrequency Technology

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044614
Enrollment
Unknown
Registered
2021-03-24
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female Stress Urinary Incontinence

Interventions

radio frequency treatment group:radio frequency treatment
pelvic floor muscle training group:pelvic floor muscle training

Sponsors

Fujian Provincial Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 and = 2g is positive, 2g <= urine leakage volume < 10g. 3. Subjects participate in clinical trials voluntarily and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those with metal foreign bodies in the treatment area; 2. Those with sexually transmitted diseases, HIV infection, etc.; 3. Those with past surgical treatment of urinary incontinence, and with pelvic floor surgery histroy in the past six months; 4. Those with POP-Q staging of genital prolapse greater than II degree; 5. Those with acute inflammation and infection of the reproductive tract , Bleeding, etc.; 6. Pregnant women and within half a year after delivery; 7. Those who have been using drugs that may affect bladder function or are receiving other treatments for stress urinary incontinence; 8. Those suffered from reproductive tract precancerous lesions, malignant tumors, severe heart disease , Brain, kidney, immune, blood and other systems, as well as mental, neuropsychological diseases, etc.; 9. Those with impaired consciousness and communication barriers cannot cooperate with the trial; 10. Those who are thinked of not suitting for participating in this clinical trial by the investigators .

Design outcomes

Primary

MeasureTime frame
Urine leakage;

Secondary

MeasureTime frame
Number of urine leaks;ICIQ-SF ??;PGI-I;PISQ-12;

Countries

China

Contacts

Public ContactSong yanfeng

Fujian Provincial Maternity and Child Health Care Hospital

719421512@qq.com+86 13905909403

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026